Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Sales | 16,896 | 6,236 | 502 | 0 | 13,200 |
| Cost of Goods | 423 | 394 | 19 | N/A | 0 |
| Gross Profit | 16,473 | 5,842 | 483 | N/A | 13,200 |
| Operating Expenses | 115,683 | 89,721 | 56,404 | 37,470 | 40,820 |
| Operating Income | -98,787 | -83,485 | -55,902 | -37,470 | -27,620 |
| Interest Expense | 11,240 | 5,988 | 544 | 502 | 430 |
| Other Income | 60,124 | 9,200 | 4,517 | 1,692 | 3,080 |
| Pre-tax Income | -49,903 | -80,273 | -51,929 | -36,280 | -24,970 |
| Net Income Continuous | -49,903 | -80,273 | -51,929 | -36,280 | -24,972 |
| Net Income | $-49,903 | $-80,273 | $-51,929 | $-36,280 | $-24,970 |
| EPS Basic Total Ops | -17,756.45 | -28,914.21 | -24,835.03 | -32,033.59 | -19,436.11 |
| EPS Basic Continuous Ops | -17,732.91 | -28,475.06 | -24,581.71 | -27,988.23 | -19,209.23 |
| EPS Diluted Total Ops | -17,756.45 | -28,914.21 | -24,835.03 | -32,033.59 | -19,436.11 |
| EPS Diluted Continuous Ops | -17,732.91 | -28,475.06 | -24,581.71 | -27,988.23 | -19,209.23 |
| EBITDA(a) | $-84,547 | $-71,248 | $-45,469 | $-35,282 | $-25,540 |